Abstract
T-cell prolymphocytic leukemia (T-PLL) is a rare postthymic T-cell disorder. The disease is characterized by lymphadenopathy, splenomegaly, skin lesions, a high white blood cell count, and an aggressive clinical course. The small cell variant of T-PLL occurs in approximately 20% of patients. Most T-PLL patients express membrane T-cell receptors (TCR) of the γ βphenotype. The diagnosis of small cell variant T-PLL in a 56-year-old woman was based on the findings of abnormal lymphocytosis, immunophenotype, lymphadenopathy, and aggressive clinical behavior. Immunophenotype analysis showed that lymphocytes were positive for CD2, CD3, CD5, CD7, CD8, and TCR γ δ antigens and negative for CD1a, CD4, and TCR α β antigens. Southern blot analysis revealed rearrangement of the TCR Jγ and Jδ-1 genes. A cytogenetic study of peripheral blood showed a normal karyotype. T-PLL with a TCR α βphenotype is very rare. This case was typical T-PLL except for the morphologically small cell type and the lack of the typical chromosome aberration. If cases accumulate in the future, the specific features of the γ δ type of T-PLL will become clearer.
Similar content being viewed by others
References
Matutes E, Brito-Babapulle V, Swansbury J, et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood. 1991;78:3269–3274.
Matutes E, Garcia Talavera J, O’Brien M, Catovsky D. The morphological spectrum of T-prolymphocytic leukemia. Br J Haematol. 1986;64:111–124.
Herling M, Khoury JD, Washington LT, Duvic M, Keating MJ, Jones D. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood. 2004;104:328–335.
Gandhi V, Plunkett W, Weller S, et al. Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells. J Clin Oncol. 2001;19:2142–2152.
Dearden CE, Matutes E, Cazin B, et al. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H. Blood. 2001; 98:1721–1726.
Sugimoto T, Imoto S, Matsuo Y, et al. T-cell receptor γ δ T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype. Ann Hematol. 2001;80:749–751.
Groh V, Porcelli S, Fabbi M, et al. Human lymphocytes bearing T cell receptor γ/ δ are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med. 1989;169:1277–1294.
Picker LJ, Brenner MB, Michie S, Warnke RA. Expression of T cell receptor delta chains in benign and malignant T lineage lymphoproliferations. Am J Pathol. 1988;132:401–405.
Saito T, Matsuno Y, Tanosaki R, Watanabe T, Kobayashi, Tobinai K. γ δ T-cell neoplasms: a clinicopathological study of 11 cases. Ann Oncol. 2002;13:1792–1798.
Schott G, Sperling C, Schrappe M, et al. Immunophenotypic and clinical features of T-cell receptor γ δ+ T-lineage acute lymphoblastic leukemia. Br J Haematol. 1998;101:753–755.
Yamaguchi M, Ohno T, Nakamine H, et al. γ δ T-cell lymphoma: a clinicopathologic study of 6 cases including extrahepatosplenic type. Int J Hematol. 1999;69:186–195.
Gaulard P, Bourquelot P, Kanavaros P, et al. Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Am J Pathol. 1990;137:617–628.
Zech L, Gahrton G, Hammarstrom L, et al. Inversion of chromosome 14 marks human T-cell chronic lymphocytic leukaemia. Nature. 1984;308:858–860.
Brito-Babapulle V, Pomfret M, Matutes E, Catovsky D. Cytogenetic studies on prolymphocytic leukemia, II:T cell prolymphocytic leukemia. Blood. 1987;70:926–931.
Jonveaux P, Daniel MT, Martel V, Maarek O, Berger R. Isochromosome 7q and trisomy 8 are consistent primary, non-random chromosome abnormalities associated with hepatosplenic T gamma/delta lymphoma. Leukemia. 1996;10:1453–1455.
Author information
Authors and Affiliations
About this article
Cite this article
Toyota, S., Nakamura, N. & Dan, K. Small Cell Variant of T-Cell Prolymphocytic Leukemia with a γδ Immunophenotype. Int J Hematol 81, 66–68 (2005). https://doi.org/10.1532/IJH97.04129
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1532/IJH97.04129